Professional Documents
Culture Documents
Stroke can affect all ages. The most productive age peak is between the ages of
40-60 years. Slightly more men than women at age <60 years and became just as
much at the age of> 60 years. In case someone has a stroke, comprehensive
treatment should start from the hyperacute phase to the chronic. This
comprehensive governance aims to reduce mortality and disability. Treatment was
started from pre hospital, emergency room, treatment in a stroke unit / stroke
corner, the plan to return to the restoration / rehabilitation with the ultimate goal
can be more independently andpatients have a good quality of life. Treatment
measures duly carried out on the basis of evidence based. In the application of
evidence-based is preferably adjusted to the maximum conditions of service
centers that we have. Stroke PNPK book is generally intended to provide a
comprehensive governance manual includes pre-hospital stroke treatment,
definitive therapy in the hospital and referral systems. PNPK is expected to be a
reference guide for the neurologist or general practitioner who handle cases /
issues stroke.
Page 1 of 44
Page 2 of 44
Page 3 of 44
monitoring) should be performed during the first 24 hours after the onset
of ischemic stroke (Class I, Level Evidence B).
Early general physical examination
-
deterioration in the first days after stroke (Class I, Level Evidence B).
Monitor intra-cranial pressure should be in pairs in patients with GCS <9
and patients who experienced loss of consciousness due to the increase in
Evidence C).
Corticosteroids are not recommended to cope with brain edema and
intracranial high pressure in ischemic stroke, can be given if believed there
Page 4 of 44
Control of seizures
-
Evidence C).
On the stroke of intracerebral hemorrhage can be given prophylactic
antiepileptic drugs, for 1 month and then lowered and stopped when no
seizures during treatment (Class V, Level Evidence C).
Every stroke patients with febrile should be treated with antypiretics and
addressed the cause (Class I, Level Evidence C).
Supporting investigation
-
Page 5 of 44
enteral).
Fluid balance calculated by measuring the production of urine a day plus
the discharge that is not perceived (daily urine output plus 500 ml of fluid
loss is not visible and added another 300 ml per degree Celsius in patients
with heat).
Electrolytes (sodium, potassium, calcium, magnesium) should always be
checked and replaced if there is a shortage of all to achieve the normal
value.
Acidosis and alkalosis should be corrected in accordance with the results
Nutrition
-
Enteral nutrition has to be given at the latest within 48 hours, oral nutrition
composition:
Carbohydrates 30-40% of total calories.
Fat 20-35% (on a breathing disorder may be higher 35-55%).
Protein 20-30% (in a state of stress protein requirement 1. 4-2. 0 g / kg /
consider gastrostomy.
In certain circumstances that enteral nutrition is not possible, nutritional
Page 6 of 44
-decubitus mattress.
Prevention of DVT and pulmonary embolism
In certain patients at risk for DVT should be given subcutaneous heparin
5000 IU twice daily or LMWH or heparinoid. (Level Evidence A).
influencing ICT.
Mobilization stages if hemodynamic and respiratory stability.
Full bladder is emptied, preferably with intermittent catheterization.
Further investigations such as laboratory tests, MRI, MRA, CTA, Carotid
Duplex Sonography, Transcranial Doppler (TCD) (Class I, level A),
polysomnography (class IIb level B), Cerebral DSA (Class IIA, Level B),
Trans
thoracic
echocardiography
(TTE),
Trans
Esophageal
Echocardiography (TEE) (class III, level B), and others carried out in
-
accordance with the indications and to look for risk factors for stroke.
Rehabilitation.
Family education.
Discharge planning (management plan for patients outside the hospital)
Page 7 of 44
Evidence A)
Aspirin should not be used as a substitute for acute stroke intervention
thrombolytic drugs are not recommended (Class III, Level Evidence A).
Provision of clopidogrel alone, or in combination with aspirin, in acute
ischemic stroke, is not recommended (Class III, Level Evidence C), except
in patients with specific indications (eg. Unstable angina or non-Q-wave
MI, or recent stenting: treatment must been given until 9 months after the
event (class I level evidence A).
Page 8 of 44
Evidence A).
The use of vasodilators such as Pentoxifylline not recommended in the
Page 9 of 44
C).
Anticoagulants may be effective in patients with acute cerebral venous
b. Resting in bed alone is not enough to prevent rebleeding PSA, but can
generally be considered to be a treatment strategy that subsequently
become the gold standard (Class IIb, Level Evidence B).
Page 10 of 44
e. The use of intra-luminal coils and balloons still testing. Lebih lanjut
research is still required (class IV-V, Level Evidence C).
Page 11 of 44
Prevention of vasospasm:
- Delayed vasopasme
8.5 antifibrinolytic
The drugs most often used are epsilon-amino acid at a dose caproid 36
grams / day or tranexamat acid at a dose of 6-12 g / day.
8.6 Antihypertensive
b. Antihypertensive drugs are given if the TDS is more than 160 mmHg
and TDD over 90 mmHg or above 130 mmHg MAP
d. To keep the TDS not decreased (below 120 mm Hg) may be given
vasopressor, where it is to protect the ischemic penumbra tissue that may
occur due to vasospasm.
8. 7 Hyponatremia
8. 8 Seizures
8.9 hydrocephalus
a. Acute (Obstruction)
Can occur after the first day, but more often within the first 7 days. It
happened
approximately
20%
of
cases,
it
is
recommended
Page 13 of 44
b. Chronic (communicant).
b. Analgesics:
- Avoid aspirin
propofol 3-1 mg / kg / h. 20
H2 Antagonist
Antacids
Bibliography
Appendix 1.
Background
Control of risk factors that can not be modified can not be changed and
can be used as a marker (marker) stroke in a person.
9.1.1.1 Hypertension
AHA / ASA
Class I Level A:
Class II level B:
Page 16 of 44
9.1.1.2 Diabetes
AHA / ASA
1. Class II level B:
Target blood sugar control and blood pressure levels in patients with
diabetes is recommended for patients who have suffered a stroke or TIA.
ESO 2008.
Patients with type 2 diabetes who do not need insulin, treatment with
pioglitazone is recommended after stroke.
3. Class IV GCP
9.1.1.3 Lipids
AHA / ASA
a. Class I level A:
Page 17 of 44
b. Class I level B:
Class II A level B:
Patients with ischemic stroke or TIA with low HDL C can be considered
the treatment with niacin or gemfibrozil.
AHA / ASA
Class I level A:
Class I level C
Class II level C
Page 18 of 44
9.1.2.1 Smoking
AHA / ASA
Class I level C
Health care should provide advice to every patient with stroke or TIA with
a history of smoking to quit smoking immediately.
Patients with ischemic stroke or TIA who become heavy alcohol drinkers
should stop or reduce consumption of alcohol.
AHA / ASA
Page 19 of 44
Patients with ischemic stroke or TIA who are still able to perform
physical activity, at least 30 minutes of moderate-intensity physical
exercise can be considered to lower the risk factors and comorbid
conditions that increase the likelihood of recurrent stroke (moderate
intensity physical activity was defined as significant to sweating or
increasing the rate heart 1-3kali per week).
AHA / ASA
Class I level A
Patients with a history of TIA or ischemic stroke within the last six months
and patients with severe ipsilateral carotid artery stenosis (70-99%) is
recommended to undergo CEA (carotid endarterectomy), if the risk of
morbidity and mortality estimated periopreratif <6%.
Class I level B
Page 20 of 44
Patients with symptomatic severe stenosis (> 70%) are difficult to access
surgically, a common condition that can increase the risk of surgery or
there are specific conditions such as radiation-induced stenosis or
restenosis after CEA, considered to undergo CAS.
Class I level B
AHA / ASA
Class I level B
Stroke or TIA patients with intracranial stenosis of blood vessels in the 5099%, recommended aspirin compared to warfarin. Based on data for the
general safety and effectiveness of the recommended dose of aspirin 50mg
to 325mg per day.
Stroke or TIA patients with intracranial stenosis of blood vessels in the 5099%, blood pressure <140 / 90mmHg and total cholesterol <200 mg / dl is
the maintenance of long-term targets that can be suggested.
Stroke or TIA patients with intracranial stenosis of blood vessels in the 5099%, angioplasty and stenting unknown or benefits and still under further
investigation.
AHA / ASA
Page 22 of 44
Class I level A
Class I level B
Patients who can not regularly check the INR can be given dabigatran
etexilate. This administration needs to be monitored carefully because
until now there is no medication that can stop bleeding complications.
Class II level C
Patients with atrial fibrillation and a high risk of stroke (stroke or TIA
within the last 3 months, CHADS score of 5 or 6, mounted mechanical
valves or rheumatic heart disease) who require oral anticoagulant therapy
may be considered temporary got bridging therapy with LMWH
subcutaneous administration .
Left Heart
AHA / ASA
Class I level B
Page 23 of 44
AHA / ASA
AHA / ASA
Patients with ischemic stroke or TIA who also suffered from rheumatic
mitral valve with or without the presence of atrial fibrillation, long-term
warfarin with a target INR of 2.5 is recommended (range 2.0-3.0).
AHA / ASA
Page 24 of 44
Patients with ischemic stroke or TIA are accompanied with aortic valve
disease or mitral valve disease nonreumatik and do not suffer from atrial
fibrillation, antiplatelet treatment is recommended.
Patients with ischemic stroke or TIA and mitral annular calcification may
consider granting antiplatelet treatment.
For patients with ischemic stroke or TIA who also suffered from mitral
valve prolapse, the provision of long-term antiplatelet therapy may be
considered.
AHA / ASA
AHA / ASA
Class I level B
Ischemic stroke and TIA patients were also installed protestik mechanical
heart valves, warfarin with a target INR recommended 3.0 (range 2.5-3.5).
Patients with heart valve mounted mechanical protestik and had suffered a
stroke or systemic embolism, although it has received adequate treatment
with oral anticoagulants, aspirin 75mg / day to 100 mg / day may be given
in addition to maintaining a target INR of 3.0 (range 2,5- 3.5) if the patient
does not have a high risk of bleeding (bleeding history, varicose veins,
vascular anomalies or known to have a great risk of bleeding,
coagulopathy).
Page 25 of 44
Patients with ischemic stroke or TIA who also has a bioprosthetic heart
valve without there are other sources that have thromboembolic risk,
anticoagulant treatment with warfarin INR2,0 (2.5-3.5) may be considered.
AHA / ASA
Class I level A
Japanese Guidelines
Class I level A
Cilostazol (100 mg) two times a day showed a significant effect on the
incidence penurinan recurrent stroke compared to placebo and effective to
prevent lacunar infarction in the differential analysis.
ESO
Class IA
Page 27 of 44
Class I:
Benefits over antiplatelet therapy for patients with ischemic stroke or TIA
and carotid dissection of the vertebral artery ektrakranial or unknown.
Page 28 of 44
Class I:
AHA / ASA
There were no definitive data that anticoagulation has the same effect or
better than aspirin for secondary stroke prevention in patients with PFO.
Not found data that recommended for PFO closure in patients with stroke
and PFO.
9.1.6.3 hyperhomocysteinemia
AHA / ASA
AHA / ASA
Class I level A
Page 29 of 44
AHA / ASA
Adult patients with SCD and stroke recommended common therapy that
can be applied to control the risk factors and the use of anticoagulants.
AHA / ASA
Page 30 of 44
AHA / ASA
Class I level B
Class I level C
9.1.6.8 Pregnancy
AHA / ASA
In pregnancies with stroke or TIA coupled with a high risk for the
occurrence of thromboembolic processes (hypercoagulable state or
artificial heart valves), the following conditions may be considered.
Adjustment of the dose of heparin during pregnancy for example with
subcutaneous dosing every 12 hours while in monitor aPTT. Adjusted dose
of LMWH is accompanied by a monitor Xa anti-factor during pregnancy
progresses, or LMWH until week 13 followed by administration of
heparin until the second or third semester of pregnancy, and then given
back LMWH until delivery.
Page 31 of 44
AHA / ASA
Class I level B
Page 32 of 44
EMERGING THERAPY
Plasmin:
-
hemispheres
Seizures at the time of stroke onset
Seizures with neurological sequelae post-ictal abnormalities
History of stroke or severe head injury in the previous 3 months
Active bleeding or acute trauma (fracture) on physical examination
History of major surgery or severe trauma within the previous 2 weeks
P dstinal history of bleeding or urinary tract in 3 weeks earlier
Systolic blood pressure> 185 mmHg, diastolk> 110 mmHg
Blood glucose <50 mg / dl or> 400 mg / dl
Symptoms of subarachnoid hemorrhage
Arterial puncture in place that cannot be compressed or lumbar
aPTT
The clinical features of myocardial infarction their pericarditis
Myocardial infarction within the previous 3 months
Pregnant women
Not currently taking oral anticoagulants or when you are in the
Page 35 of 44
Page 36 of 44
Page 37 of 44
need
close
monitoring
to
see
signs
of
Page 39 of 44
for blood screening, and do not have the risk of overload. INR
improved rapidly after administration of PCC.
d. Recombinant factor VIIa (rfVIIa). Can be at high risk of thrombotic
process so it does not get FDA approval for reversal of anticoagulant
drugs on bleeding stroke.
3. Blood Pressure Correction. Indications administration of antihypertensive
drugs that systolic blood pressure> 200 mm Hg or MAP> 150 mmHg 2.
Blood pressure is lowered by about 15% per day, the preferred use of
antihypertensive drugs with short working (short-acting) so that the dose
can be titrated and adjusted to the blood pressure response and
neurological status of the patient. 2 medications that can be used is
nicardipine, labetalol, esmolol or sodium nitroprusside.
a. Nicardipine 5 mg / h as an initial dose, then raised 2, 5 mg / h every 5
minutes until the desired effect. Maximum dose is 15mg / h.
b. Labetalol given intermittent doses of 10-20 mg IV in 2 minutes, then
40-80 mg IV every 10 minutes to achieve the desired blood pressure.
Can be converted to an oral dose of 200-400 mg every 6-12 hours.
c. Hydralazine can be given 10-20 mg IV every 4-6 hours
d. Enaloprilat can be given 0, 625-1, 2 mg IV every 6 hours
e. Sodium nitroprusside should be avoided in case of emergency
neurology because it can increase ICP. But if it takes the blood
pressure drops immediately and other drugs are not effective, the
patient can be given sodium nitroprusside 0, 25-10 ig / kg / min. The
initial dose should be lower.
4. Management of Arterial Hypertension Emergency 2
a. If TD systole> 200 mm Hg or MAP> 150 mmHg, lower TD quickly
with IV medications and monitor TD every 5 minutes.
b. If TD systole> 180 mm Hg or MAP> 130 mmHg and there is evidence
of increased intracranial pressure, lower TD continuously or
intermittently, and maintain CPP> 80 mmHg.
c. If TD systole> 180 mm Hg or MAP> 130 mmHg and there is no
evidence of increased intracranial pressure, lower TD lightly with
continuous or intermittent.
5. Maintaining cerebral perfusion pressure (CPP)
Page 40 of 44
Page 41 of 44
B. Indications Surgery
a. Cerebellar hematoma with a diameter> 3 cm were accompanied
suppression and brain stem or hydrocephalus due to obstruction of the
ventricular should be done with as soon as possible. 2, 5 (Class I, Level of
Evidence B)
b. Bleeding with structural abnormalities such as an aneurysm or AVM.
(Class III-V, Level of Evidence C)
c. Lobar hematoma with medium-large size which is located close to the
cortex (<1 cm) 2, 5 in patients with age <45th with GCS 9-12 5,
evacuation of supratentorial ICH by standard craniotomy can be
considered. 2 (Class IIb, Level of Evidence B)
d. Evacuation of supratentorial ICH routine with standard craniotomy within
96 hours is not recommended (Class III, Level of Evidence A). Exception
in lobar hematoma 1 cm from the cortex. Management neuro intervention
in cases of bleeding stroke can be done in an effort to find the cause of the
bleeding and its management. Digital cerebral angiography examination
Substraction can be done if there is suspicion of the cause is an
arteriovenous malformation or fistula. (Class IIb, level of evidence B)
e. Provision of appropriate antiepileptic drugs should always be used for the
treatment of clinical seizures in patients with ICH. (Class I, Level of
Evidence B) 4. Giving antiepileptic prophylaxis in a short time due to ICH
can reduce the risk of seizures in patients with lobar hemorrhage5. (Class
IIb, Level of Evidence C). Consider the 24-hour EEG monitoring in
patients with coma (GCS <8), including in patients with supratentorial
intracerebral hemorrhage deep, Keppra can be given IV or fosphenytoin as
prophylaxis.
f. Prevention of recurrent ICH. Treatment of hypertension in non-acute
setting is very important to reduce the risk of recurrent ICH and ICH.
(Class I, Level of Evidence A). Smoking, heavy alcoholism and cocaine
use is a risk factor for ICH and kick the habit should be recommended for
the prevention of ICH. (Class I, Level of Evidence B)
Intracerebral Hemorrhage Management Recommendations:
Page 42 of 44
1.
2.
3.
4.
5.
6.
Correction of coagulopathy
Blood Pressure Correction
Maintaining cerebral perfusion pressure (CPP)
Surgical management
Provision of antiepileptic drugs
Prevention of recurrent ICH
Page 43 of 44
airway.
If there are signs of herniation of the intubation (see chapter IV, on
Page 44 of 44